Welcome https://www.the-microbiologist.com. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
Site name
Mast navigation
  • Register
  • Sign In
  • Subscribe
Search our site
Menu
Close menu
  • Home
  • News
  • Features
  • Opinion
  • Careers
  • Topics
    • Back to parent navigation item
    • Topics
    • Early Career Research
    • One Health
    • Food Security
    • Climate Action
    • Healthy Land
    • Clean Water
    • Economic Equality
    • Ocean Sustainability
  • Regions
    • Back to parent navigation item
    • Regions
    • Africa & Middle East
    • Asia & Oceania
    • The Americas
    • UK & Europe
    • USA & Canada
  • Videos
  • AMI
    • Back to parent navigation item
    • AMI
    • Community
    • Policy
    • Publishing
    • Events
    • Special Issues
    • Diversity & Inclusion
  • Home
  • News
  • Features
  • Opinion
  • Careers
  • Topics
      • Early Career Research
      • One Health
      • Food Security
      • Climate Action
      • Healthy Land
      • Clean Water
      • Economic Equality
      • Ocean Sustainability
  • Regions
      • Africa & Middle East
      • Asia & Oceania
      • The Americas
      • UK & Europe
      • USA & Canada
  • Videos
  • AMI
      • Community
      • Policy
      • Publishing
      • Events
      • Special Issues
      • Diversity & Inclusion
  • More from navigation items

Latest news

pexels-haberdoedas-33530764

Biochar can reshape how soils respond to warming, but the effect depends on the soil

2026-06-08T09:36:00+01:00

A new study shows that biochar can change how strongly soil nitrous oxide emissions respond to rising temperatures. But the effect is not one-size-fits-all. The study found that nitrous oxide emissions increased with warming in both agricultural soil and forest soil, but forest soil was more temperature-sensitive than agricultural soil. 

Human_Respiratory_Syncytial_Virus_(RSV)_-_52456179236

Maternal RSV vaccine cuts infant hospitalizations by 70%

2026-06-08T09:29:00+01:00

A study has found that vaccination against respiratory syncytial virus (RSV) during pregnancy reduced the risk of hospitalization in young infants by nearly 70%. It provides early real-world evidence from U.S. clinical care, showing that administering one dose of the maternal RSV vaccine (RSVpreF vaccine) reduces hospitalization related to RSV in young infants. 

Low-Res_PXL_20260528_183512874.PORTRAIT

Flu drugs show promise against cognitive decline

2026-06-08T09:22:00+01:00

A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection. Scientists identified a new biological culprit: the degradation of protective sugar molecules in our bodies, known as glycans, that normally help keep inflammation in check. 

Low-Res_IMG_1297

Data from patients hospitalised with COVID-19 made available to the scientific community

2026-06-08T09:14:00+01:00

The DIVINE study database has been published. The cohort includes clinical information from 5,813 patients hospitalised with COVID-19 during four waves of the pandemic, between March 2020 and August 2021, across five hospitals in the southern metropolitan area of Barcelona. 

Cannibal

Researcher discovers single-celled organism that transforms into cannibalistic supergiant

2026-06-04T15:54:00+01:00

Researchers have discovered a microscopic organism that can transform into a cannibalistic ’supergiant’ that drastically changes size, shape, and behavior, and abandons filter-feeding to hunt and consume their genetically identical relatives. 

Low-Res_cover

From spider silk to science: a new way to access hidden fungal diversity

2026-06-04T15:44:00+01:00

A new study suggests that spider webs - particularly those incorporating environmental debris - can serve as natural, non-destructive collectors of fungal material in agricultural ecosystems. The findings show that viable fungi can be recovered from these structures, including lineages that may represent previously undocumented diversity.

All news content

Research

pexels-haberdoedas-33530764

Biochar can reshape how soils respond to warming, but the effect depends on the soil

2026-06-08T09:36:00+01:00

A new study shows that biochar can change how strongly soil nitrous oxide emissions respond to rising temperatures. But the effect is not one-size-fits-all. The study found that nitrous oxide emissions increased with warming in both agricultural soil and forest soil, but forest soil was more temperature-sensitive than agricultural soil. 

Human_Respiratory_Syncytial_Virus_(RSV)_-_52456179236

Maternal RSV vaccine cuts infant hospitalizations by 70%

2026-06-08T09:29:00+01:00

A study has found that vaccination against respiratory syncytial virus (RSV) during pregnancy reduced the risk of hospitalization in young infants by nearly 70%. It provides early real-world evidence from U.S. clinical care, showing that administering one dose of the maternal RSV vaccine (RSVpreF vaccine) reduces hospitalization related to RSV in young infants. 

Low-Res_PXL_20260528_183512874.PORTRAIT

Flu drugs show promise against cognitive decline

2026-06-08T09:22:00+01:00

A class of flu drugs may reduce cognitive decline and premature aging in people living with chronic viral infection. Scientists identified a new biological culprit: the degradation of protective sugar molecules in our bodies, known as glycans, that normally help keep inflammation in check. 

More Research

Industry

pexels-cdc-library-3992930

Andelyn Biosciences launches LVV Curator® Platform

2026-05-13T10:42:00+01:00

Andelyn Biosciences has announced the launch of its LVV Curator® Platform, a standardized lentiviral vector (LVV) manufacturing solution built on the same proven modular approach that supports clinical and commercial adeno-associated virus (AAV) programs.

3MA_Environment_2 (2)

Modular Clean Air strengthens position as part of Total Clean AIr

2026-05-06T13:55:00+01:00

Modular Clean Air (MCA) is now wholly owned by Total Clean Air (TCA), marking the next phase in its development following its successful launch as a joint venture in 2025.

Low-Res_Infectious Disease- TB and Non-TB- Scientists- Dartois and Dick- Lab-Office (33)

CDI breakthroughs lead to new drug development deal for deadly NTM bacteria

2026-04-22T09:11:00+01:00

Scientists have developed new compounds against non-tuberculous mycobacteria which are now the subject of a new collaboration and license agreement with the Switzerland-based and publicly listed BioVersys AG. 

more industry

Innovation

Low-Res_cover

From spider silk to science: a new way to access hidden fungal diversity

2026-06-04T15:44:00+01:00

A new study suggests that spider webs - particularly those incorporating environmental debris - can serve as natural, non-destructive collectors of fungal material in agricultural ecosystems. The findings show that viable fungi can be recovered from these structures, including lineages that may represent previously undocumented diversity.

Low-Res_virus Figure 1A

Researchers combine bacteria and viruses to demonstrate a new way to fight cancer

2026-06-04T15:03:00+01:00

Researchers have designed non-toxic Salmonella bacteria to deliver viruses that are safe to humans but potent against liver and pancreatic cancer tumors. Animal models treated with this combination of bacteria and viruses saw almost all their tumors eliminated and lived significantly longer.

image (5)

New climate-based tool predicts coral bleaching months in advance

2026-06-04T09:49:00+01:00

Researchers found that coral bleaching on a Caribbean island occurs when three major climate patterns in the Pacific and Atlantic Oceans align in specific ways that intensify ocean warming. They created a new, early-warning tool called the Bleaching Event Early Predictor (BEEP). 

more innovation

People

Low-Res_IMG_1297

Data from patients hospitalised with COVID-19 made available to the scientific community

2026-06-08T09:14:00+01:00

The DIVINE study database has been published. The cohort includes clinical information from 5,813 patients hospitalised with COVID-19 during four waves of the pandemic, between March 2020 and August 2021, across five hospitals in the southern metropolitan area of Barcelona. 

Low-Res_image-1024x683

Researcher studying probiotics to fight acid reflux and esophageal cancer

2026-06-04T10:23:00+01:00

Patients with acid reflux, which occurs when stomach acid pushes up into the esophagus, know the symptoms all too well: heartburn, belching, chest pain and trouble swallowing. Acid reflux also increases the risk of esophageal cancer, but researchers are investigating how a simple probiotic could treat and prevent both conditions. 

Gamma_phage

The future of phage therapy will be decided by more than science alone

2026-06-04T09:32:00+01:00

As antimicrobial resistance accelerates worldwide, leading experts gather in Valencia to address the scientific, regulatory, manufacturing and clinical challenges that will determine whether phage therapy becomes a routine healthcare solution.

more people

  • Issues
  • Contact us
  • Topics A-Z
  • Writers A-Z
  • Advertise with us
  • Editorial Team
  • In the Loop Newsletter

Bringing the international microbiology community together to advance scientific impact.
appliedmicrobiology.org

© Applied Microbiology International
  • Cookie Policy
  • Privacy
  • Terms of use
  • © 2022 The Microbiologist

Site powered by Webvision Cloud